Nasdaq · Healthcare

KORU Medical Systems, Inc. (KRMD)

As-reported financials and recent SEC filings for KORU Medical Systems, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$41.1M

Net income

$-2.6M

Net margin

-6.4%

Diluted EPS

$-0.06

ROE

-15.5%

P/E (TTM)

—

Market cap

—

Debt / equity

—

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$41.1M	$33.6M	$28.5M	$27.9M	$23.5M
Gross profit	$25.6M	$21.3M	$16.7M	$15.4M	$13.8M
Operating income	$-3.0M	$-6.4M	$-10.3M	$-10.8M	$-7.0M
Net income	$-2.6M	$-6.1M	$-13.7M	$-8.7M	$-4.6M
Diluted EPS	$-0.06	$-0.13	$-0.30	$-0.19	$-0.10

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

42026-07-02

42026-07-01

42026-07-01

42026-07-01

42026-07-01

42026-07-01

42026-07-01

8-K2026-06-30

Largest Healthcare peers

UNH

UNITEDHEALTH GROUP INC

All Healthcare companies →

Go deeper on KRMD

Search KORU Medical Systems, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.